本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kymera Therapeutics, Inc.

116.33
+3.182.81%
盤後116.330.00000.00%16:20 EDT
成交量:65.38萬
成交額:7,591.30萬
市值:96.73億
市盈率:-36.22
高:117.43
開:113.06
低:112.88
收:113.15
52周最高:130.05
52周最低:47.86
股本:8,315.06萬
流通股本:6,487.46萬
量比:0.94
換手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-3.2122
每股收益(LYR):-3.6900
淨資產收益率:-24.15%
總資產收益率:-15.59%
市淨率:6.41
市盈率(LYR):-31.53

資料載入中...

2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/14

重要事件披露

Form 8-K - Current report
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/20

重要事件披露

Form 8-K - Current report
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities